This collection
is approved as amended by FDA's revisions of 6/14/99 and
6/16/99.
Inventory as of this Action
Requested
Previously Approved
11/30/1999
11/30/1999
3,600
0
0
64,800
0
0
0
0
0
The proposed collection of information
concerns a survey of manufacturers of biologics products, including
both licensed biologics manufacturers and registered blood
establishments, to obtain information aobut the Year 2000
compliance status of the facilities used to manufacture regulated
products. The information will be made available to the public via
FDA's website.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.